Safety and Preliminary Efficacy of Mesenchymal Stromal Cell (ORBCEL-M) Therapy in Diabetic Kidney Disease: A Randomized Clinical Trial (NEPHSTROM). (2023)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1681/asn.0000000000000189

PubMed Identifier: 37560967

Publication URI: http://europepmc.org/abstract/MED/37560967

Type: Journal Article/Review

Volume: 34

Parent Publication: Journal of the American Society of Nephrology : JASN

Issue: 10

ISSN: 1046-6673